MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Choreiform Movements Secondary to Sarcoidosis Without Central Nervous System Granulomatosis

    O. Carranza-Renteria, T. Hammond (Boca Raton, USA)

    Objective: To share our experience managing a patient who presented with choreiform movements found to be secondary to sarcoidosis without CNS Granulomatosis. Background: Sarcoidosis is…
  • 2024 International Congress

    Diabetic striatopathy with stroke – like symptoms: A case report

    A. Alonso, C. Araque, B. Marquez (Bogotá, Colombia)

    Objective: To describe a rare case of diabetic striatopathy in a woman with type 2 diabetes mellitus presenting with unilateral hemichorea, dysarthria and left hemiparesis…
  • 2024 International Congress

    Efficacy Remaining at Time of Requested Retreatment Following Botulinum Toxin Treatment for Cervical Dystonia: Potential for a New Treatment Paradigm with DaxibotulinumtoxinA

    A. Ellenbogen, R. Hauser, A. Patel, P. Mcallister, D. Vitarella, T. Gross, R. Kazerooni, C. Gallagher, D. Hollander (Farmington Hills, USA)

    Objective: To assess the residual therapeutic efficacy of prior botulinum toxin (BoNT) injection at the patient-desired retreatment interval in cervical dystonia (CD). Background: BoNT injections…
  • 2024 International Congress

    Clinical Outcomes and Local Field Potential Characteristics in Bilateral GPi DBS in 2 cases of X-Linked Dystonia Parkinsonism

    E. Donlon, C. O'Keefe, G. Mullane, F. Ruggieri, M. Alexander, C. Moran, T. Lynch, C. Fearon, E. Pereira, R. Walsh (Dublin, Ireland)

    Objective: We describe clinical outcomes and local field potential characteristics in 2 cases of fulminant onset XDP who went on to have bilateral GPi DBS…
  • 2024 International Congress

    Structural and Functional Brain Alterations in Laryngeal Dystonia: A Coordinate-Based Activation Likelihood Estimation Meta-Analysis

    N. Kshatriya, G. Battistella, K. Simonyan (Boston, USA)

    Objective: Efforts to understand laryngeal dystonia (LD) pathophysiology using neuroimaging techniques have demonstrated altered brain structure and function in patients compared to healthy controls1-5. However,…
  • 2024 International Congress

    A Survey of Immunological Mechanisms in Cervical Dystonia

    L. Scorr, G. Kilic-Berkmen, J. Mckay, D. Sutcliffe, A. Mckeon, H. Jinnah (Atlanta, USA)

    Objective: The overall goal was to delineate which aspects of the immune system may be most relevant to the biology of CD. Background: Although several…
  • 2024 International Congress

    Non-motor symptoms in people with Huntington’s disease: use and validation of the MDS Non-Motor Scale (MDS-NMS)

    JM. Valera-Bermejo, N. Martins, O. Makos, J. Badenoch, M. Hartmann, A. Rangel-Cristales, A. Rizos, K. Ray Chaudhuri, D. van Wamelen (London, United Kingdom)

    Objective: The primary objective of this project is to validate and personalise the existing MDS-NMS scale, originally developed for Parkinson’s disease, for use in people…
  • 2024 International Congress

    Ataxia and Parkinsonism Related with CAG Expansion Size in a Cohort of Huntington’s Disease in the Brazilian Amazon Region.

    M. Della Coletta, C. Camargo, D. Brito, G. Benevides, C. Fantin, D. Cruz, M. Evangelista, F. Carvalho, M. Teles, D. Reis, E. Amaral, H. Teive (Manaus, Brazil)

    Objective: We conducted genetic and clinical assessments in 22 families, with genetic diagnosis in 51 patients with HD in the state of Amazon, Brazil. The main objectives are evaluating demographics, genetic characteristics,…
  • 2024 International Congress

    Childhood onset progressive myoclonus and ataxia in a patient with novel TBC1D2B gene mutation

    M. Gultekin, N. Basak (Kayseri, Turkey)

    Objective: Myoclonus, ataxia, tremor and dystonia have been described in some patients with TBC1D2B gene mutation. In this paper we present a patient with progressive…
  • 2024 International Congress

    Effectiveness of abobotulinumtoxinA in adults with lower limb spasticity: Results from the AboLiSh real world observational study

    A. Esquenazi, R. Zorowitz, S. Ashford, M. Beneteau, P. Maisonobe, C. Hannes, J. Jacinto (Elkins Park, USA)

    Objective: Assess longitudinal goal attainment with repeated injections of abobotulinumtoxinA (aboBoNT-A) in the lower-limb over 16-months in a routine clinical setting. Background: While the efficacy…
  • « Previous Page
  • 1
  • …
  • 151
  • 152
  • 153
  • 154
  • 155
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley